Endometriosis antibodies

and ELISA kits, proteins related to Endometriosis.

Introduction to Endometriosis

Endometriosis is a chronic and often debilitating condition affecting millions of individuals worldwide. It occurs when tissue similar to the lining of the uterus grows outside the uterine cavity, leading to inflammation, pain, and the formation of scar tissue. Common symptoms include severe menstrual cramps, chronic pelvic pain, heavy menstrual bleeding, and infertility, all of which can significantly impact daily life and well-being. Despite its prevalence, the exact causes of Endometriosis remain elusive, and current treatments primarily focus on managing symptoms rather than providing a cure. Our research is dedicated to advancing the understanding of Endometriosis through the study of specific antibodies involved in its development and progression. By harnessing the power of antibody-based therapies, we aim to develop more effective and targeted treatments, offering new hope and improved quality of life for those affected by this challenging condition.

Endometriosis biomarkers

PB9009

Anti-Progesterone Receptor/PGR Antibody Picoband®, IF analysis of Progesterone Receptor using anti-Progesterone Receptor antibody (PB9009).
Progesterone R...

PA1385

Anti-Metalloproteinase inhibitor 1 TIMP1 Antibody Picoband®, Anti-TIMP-1 antibody, PA1385, IHC(P)
IHC(P): Human Mammary Cancer Tissue...

PB9621

Anti-IL8/CXCL8 Antibody Picoband®, IHC analysis of IL-8 using anti-IL-8 antibody (PB9621).
IL-8 was detected in paraffin-embedded section of human appendicitis tissues. Hea...

Protein Name	Gene Name	Function
CA-125	MUC16	Tumor marker associated with endometriosis severity
Interleukin-6	IL6	Pro-inflammatory cytokine involved in immune response and inflammation
Tumor Necrosis Factor-alpha	TNF	Regulates immune cells and promotes inflammation in endometriosis
Vascular Endothelial Growth Factor	VEGFA	Promotes angiogenesis and blood vessel formation in endometrial lesions
Interleukin-8	CXCL8	Chemokine that attracts neutrophils and contributes to inflammatory processes
Aromatase	CYP19A1	Enzyme involved in estrogen biosynthesis, contributing to local estrogen production
HOXA10	HOXA10	Transcription factor important for endometrial receptivity and implantation
Progesterone Receptor	PGR	Mediates progesterone's effects on endometrial tissue regulation
Estrogen Receptor 1	ESR1	Mediates estrogen signaling affecting endometrial cell proliferation
Matrix Metallopeptidase 2	MMP2	Enzyme involved in extracellular matrix remodeling and lesion invasion
Matrix Metallopeptidase 9	MMP9	Facilitates tissue remodeling and angiogenesis in endometriotic lesions
Tissue Inhibitor of Metalloproteinases 1	TIMP1	Regulates matrix metalloproteinases to maintain extracellular matrix balance
Interleukin-1 beta	IL1B	Pro-inflammatory cytokine that promotes inflammation and pain in endometriosis
S100 Calcium Binding Protein A2	S100A2	Involved in cell growth and differentiation, implicated in endometriotic tissue proliferation
E-cadherin	CDH1	Cell adhesion molecule affecting cell migration and lesion stability
Integrin beta-3	ITGB3	Involved in cell adhesion and signal transduction in endometrial cells
Nuclear Factor kappa B	RELA	Transcription factor that regulates genes involved in inflammation and immune responses
Transforming Growth Factor-beta	TGFB1	Regulates cell growth, differentiation, and immune responses in endometriosis
Leukemia Inhibitory Factor	LIF	Cytokine important for implantation and endometrial receptivity
Fatty Acid Binding Protein 4	FABP4	Involved in lipid metabolism and inflammation in endometriotic tissues
Cyclooxygenase-2	PTGS2	Enzyme involved in prostaglandin synthesis, promoting inflammation and pain

Important Mechanisms

Immune System Dysfunction in Endometriosis

Endometriosis is increasingly recognized as a condition with significant immune system involvement. Researchers have identified that immune dysfunction plays a critical role in the establishment and maintenance of endometriotic lesions. In a healthy immune system, the body effectively clears retrograde menstrual debris and prevents the implantation of endometrial cells outside the uterine cavity. However, in individuals with endometriosis, this immune surveillance is impaired. Key abnormalities include altered activity of natural killer (NK) cells, increased production of pro-inflammatory cytokines, and the presence of autoantibodies. These immune irregularities create an environment conducive to the survival and growth of ectopic endometrial tissue. Additionally, chronic inflammation perpetuates pain and fibrosis associated with the disease. Understanding the immune mechanisms in endometriosis not only elucidates the pathophysiology of the condition but also opens avenues for targeted immunomodulatory therapies aimed at restoring normal immune function and alleviating disease symptoms.

Genetic and Epigenetic Factors in Endometriosis

The etiology of endometriosis is multifactorial, with genetic and epigenetic factors playing pivotal roles in its development and progression. Familial studies have demonstrated a higher prevalence of endometriosis among first-degree relatives, suggesting a hereditary component. Genome-wide association studies (GWAS) have identified several genetic loci associated with increased susceptibility to endometriosis, implicating genes involved in hormone metabolism, immune response, and cellular adhesion. Beyond genetic predisposition, epigenetic modifications such as DNA methylation, histone modification, and non-coding RNA expression significantly influence gene expression without altering the underlying DNA sequence. These epigenetic changes can lead to aberrant cellular behavior, promoting the survival, invasion, and angiogenesis of endometrial cells in ectopic locations. Furthermore, environmental factors and lifestyle choices can interact with genetic and epigenetic mechanisms, exacerbating the risk and severity of the disease. Comprehensive understanding of these genetic and epigenetic landscapes offers potential for personalized medicine approaches, enabling more effective prevention strategies and targeted treatments for individuals affected by endometriosis.